Detlev Biniszkiewicz - 03 Jan 2022 Form 4 Insider Report for iTeos Therapeutics, Inc. (ITOS)

Role
Director
Signature
/s/ Adi Osovsky, as Attorney-in-Fact
Issuer symbol
ITOS
Transactions as of
03 Jan 2022
Net transactions value
-$115,150
Form type
4
Filing time
04 Jan 2022, 20:41:35 UTC
Previous filing
21 Jun 2021
Next filing
10 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITOS Common Stock Options Exercise $66,500 +3,500 $19.00 3,500 03 Jan 2022 Direct F1
transaction ITOS Common Stock Sale $181,650 -3,500 -100% $51.90 0 03 Jan 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITOS Stock Option (Right to Buy) Options Exercise $0 -3,500 -21% $0.000000 13,108 03 Jan 2022 Common Stock 3,500 $19.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2021.